China Re adds new independent director to board committee

China Re adds new independent director to board committee | Insurance Business Australia

Reinsurance

China Re adds new independent director to board committee

She holds a host of board roles with top firms

Reinsurance

By
Kenneth Araullo

China Reinsurance (China Re) has confirmed that Ye Mei has officially started her role as a director following approval by the National Administration of Financial Regulation (NAFR), as previously announced on December 20, 2023.

Her term commenced on February 29, 2024, and will continue until the end of the fifth board session.

Ye’s career includes a wealth of roles across a number of companies in re/insurance and other industries. Concurrent to this position, she also holds board roles with Jamieson Wellness, Bekaert, Rhodes Trust, and the New York Military Academy (NYMA).

Prior to this, she held roles at Eurazeo, McKinsey & Company, Hansgrohe, Stanford Global Projects Center, Shenwan Hongyuan Group, Gartner/Dataquest, and more.

Details on Ye’s background and other required disclosures of the Hong Kong Stock Exchange’s Listing Rules were first provided in a supplemental circular dated February 17, 2023. Ye is taking on positions on the audit committee, risk management committee, and as a member and chair of the related-party transactions control committee.

With her addition, the list of complete board of directors for China Re is as follows:

He Chunlei (chairman)
Zhuang Qianzhi (vice chairman)
Wang Xiaoya (non-executive director)
Yang Changsong (non-executive director)
Li Wenfeng (non-executive director)
Jiang Bo (independent non-executive director)
Dai Deming (independent non-executive director)
Ye Mei (independent non-executive director)

What are your thoughts on this story? Please feel free to share your comments below.